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INTRODUCTION
Soft tissue tumours are classified according to the
tissue they appear as: such as muscle, fat, fibrous tissue,
vessels and nerves. Rhabdomyosarcoma is the most
common soft tissue sarcoma of childhood and
adolescence, and is a skeletal muscle tumour. It occurs
in any anatomic location, although mostly in the head,
neck or genitourinary tract where there is normally
relatively little skeletal muscle involved (1). Skeletal
muscle is only involved in the body extremities (2).
Rhabdomyosarcoma is malignant; in contrast, the
benign variant, rhabdomyoma, is very rare.
Rhabdomyosarcoma tends to present as an expanding
mass, resulting in pain and symptoms related to the
compression of nearby structures. Metastases can lead
to pain in the bones, difficulty with respiration due to
lung nodules or pleural effusion, anemia,
thrombocytopenia, and neutropenia, with 5-year
survival rate less than 30% (3). In contrast, confined
disease treated with combined surgery, radiation and
chemotherapy has a 5-year survival rate of over 80%
(3). The incidence of rhabdomyosarcoma is 6 cases per
100,000 per year in the United States, and
approximately 87% of patients are under 15 years of
age (3). It is valuable for medical students to understand
an example of a clinical case of pediatric embryonal
rhabdomyosarcoma. An awareness of the typical
investigations and the general prognosis in a case of
pediatric embryonal rhabdomyosarcoma allows
medical students to consider this type of tumour in their
differential diagnoses, when appropriate.
THE CASE
The father of 9-year-old Bobby from London, Ontario
took his son to the emergency department at Victoria
Hospital. Bobby had a 5-day history of right neck
swelling and tenderness, and dysphagia, a sensation of
food sticking in his throat. No other physical findings
of interest were noted. His temperature was not
elevated and he was not short of breath.
Among the differential diagnoses the emergency
physician considered based on her physical exam were
benign and malignant neoplasms, inflammatory
disease, vascular tumours, Burkitt lymphoma, Ewing's
sarcoma, and neuroblastoma, as well as
rhabdomyosarcoma (3, 4). The initial approach to
diagnosis included imaging to localize the disease,
followed by open neck biopsy for tissue diagnosis.
Figure 1. The cells demonstrated a typical small round blue cell
tumour phenotype. Mitotic activity, mitotic figures, and prominent
nucleoli were noted. Upon close inspection, tadpole-shaped and
tennis-racquet shaped cells can be observed, resembling primitive
skeletal muscle (10).
A T1 MRI was obtained to determine the radiological
features of Bobby's neck area, showing an obvious
large mass in the right anterior lateral neck. A week
later, an open neck biopsy was performed.
Histologically, the highly cellular samples showed
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hyperchromatic irregular nuclei were readily visible.
The cells demonstrated a typical small round blue cell
tumour phenotype (See Figure 5). Mitotic activity,
mitotic figures, and prominent nucleoli were noted.
Upon inspection, tadpole-shaped and tennis-racquet
shaped cells resembling primitive skeletal muscle were
noted. These histological features, along with the
patient's young age and the location of the neck mass
resulted in the final diagnosis of rhabdomyosarcoma.
Several histochemical stains were key in arriving at this
conclusion (5). 
Figure 2. A Desmin stain was positive, indicating the presence of
muscle cells (10). 
Figure 3. A MyoD1 stain, an immunohistochemical stain, was also
performed. This is a primitive transcription factor that regulates
Desmin production, and the stain confirmed the muscle origin of the
tumour and its primitive characteristics (10).
Further special stains were performed for
confirmation, classification and to determine prognostic
information. In Bobby's case, a Desmin stain was
positive, indicating the presence of muscle cells (See
Figure 9). Desmin is an intermediate filament protein
present in smooth muscle cells, striated muscle cells and
myocardium. A MyoD1 stain, an immunohistochemical
stain, was also performed, and found to be positive  (See
Figure 10). MyoD1 is a primitive transcription factor
that regulates Desmin production, and confirmed the
muscle origin of the tumour and its primitive
characteristics. A PAS stain was performed, which was
pink to indicate the presence of glycogen and/or mucin
(See Figure 7). A further PASD stain was performed, in
which the diastase enzyme would ingest glycogen. This
test indicated the presence of glycogen (See Figure 8).
Finally, a Reticalin stain was performed, which showed
a distinct pattern of cellularity typical in embryonal
rhabdomyosarcoma (See Figure 6) (5). 
Figure  4. A PAS stain was performed, which was pink to indicate the
presence of glycogen and/or mucin (10). 
Figure  5. A further PASD stain was performed, in which the diastase
enzyme would ingest glycogen. This test indicated the presence of
glycogen (10). 
Thus, histopathological analysis confirmed that the
tumour was embryonal rhabdomyosarcoma. This type
of rhabdomyosarcoma is the most common, and it is
typically composed of elongated pleomorphic tumour
cells with a centrally located hyperchromatic nucleus
surrounded by a significant amount of eosinophilic
cytoplasm. These tumours include primitive
mesenchymal cells with varying stages of18 McGill Journal of Medicine 2007
morphological skeletal muscle differentiation, such as
strap cells and striated cytoplasm, in a loose, myxoid or
cellular collagenous stroma. There can be nuclear
pleomorphism (6).
Figure 6. A Reticalin stain was performed, which showed a distinct
pattern of cellularity typical in embryonal rhabdomyosarcoma (10).
On histologic examination, embryonal
rhabdomyosarcoma cells have high cytologic
variability, representing several stages of skeletal
muscle morphogenesis. They can appear to be highly
differentiated neoplasms containing rhabdomyoblasts
with large amounts of eosinophilic cytoplasm and cross
striations, but more commonly appear as poorly
differentiated tumor cells than as highly differentiated
cells. They also have particular molecular
characteristics. Embryonal rhabdomyosarcoma cells
show a consistent loss of the material from the 11p15
region (the short arm of chomosome 11), and also have
a lack of gene amplification. In addition, the cellular
DNA content of embryonal rhabdomyosarcoma is
hyperdiploid, with approximately 1.1-1.8 times the
normal DNA (7).
DISCUSSION
Since the tumour was in the neck, local to an area of
numerous delicate structures, the tumour compressed
Bobby's esophagus, thereby causing his swallowing
difficulties and leading to the sensation of food sticking
in his throat (See Figures 1, 2, 3 and 4).
The identification of rhabdomyosarcoma and its
subtypes is important because alveolar
rhabdomyosarcoma has been reported to have a poor
prognosis and to be associated with a greater frequency
of disseminated metastases. The diagnosis of most
pediatric solid tumours requires extensive
immunohistochemical markers because they often
exhibit a nonspecific small round cell tumour
phenotype (6). There are 3 commonly used staging
systems for rhabdomyosarcoma: clinical
(surgicopathologic), TNM, and IRS (Intergroup
Rhabdomyosarcoma Study) staging (4). IRS clinical
grouping is particularly useful because previous studies
have indicated comparatively favourable and
unfavourable prognostic groups. The IRS classification
includes four groups, based on tumour respectability
(7). Group 1 includes localized disease, completely
resected. Group 2 includes total gross resection with
evidence of regional spread. Group 3 includes
incomplete resection with gross residual disease.
Finally, Group 4 includes distant metastatic disease
present at onset. 
Figure  7. The MRI shows a large, well-defined lobulated solid mass
lesion located in the right masticator space deep to the angle of the
right mandible (10).
Figure 8. The MRI shows that the mass is approximately 5.2 x 4.3 cm
(AP x transverse), centered in the right half of the face/neck  (10).
While most cases of pediatric rhabdomyosarcoma are
sporadic, risk factors include: neurofibromatosis, Li-
Fraumeni syndrome, Costello syndrome, Noonan
syndrome, Beckwith-Wiedemann syndrome, and
parental use of cocaine or marijuana. One-third of
pediatric rhabdomyosarcoma cases occur in the head
and neck region, and 90% of all cases occur in patients
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less than 25 years of age. In addition, males are affected
1.5 times more often than females. The five
embryological subtypes of rhabdomyosarcoma include:
embryonal, alveolar, botryoid, spindle cell, and
anaplastic (4). Approximately 60% of all newly
diagnosed rhabdomyosarcomas are of embryonal type,
and usually happen in younger children (1, 8). 
With combined modality therapy - chemotherapy,
radiation therapy, and surgery - the overall survival rate
for all pediatric rhabdomyosarcomas is 71% (8).
Younger patients tend to have a more favourable
prognosis, for unknown reasons (9). Multimodality
treatment is typically recommended for cases of
pediatric rhabdomyosarcoma. In cases of pediatric
rhabdomyosarcoma, the need for surgery depends on
the anatomical site of the tumour. Bobby was sent for an
oncology consult, and received chemotherapy
(Vincristin, Dactinomycin with Cyclophosphanide)
followed by adjuvant radiation therapy. At follow-up,
Bobby was recovering well. 
Figure  9. The MRI shows smaller, cystic regions scattered in the
mass lesion. It extends medially to affect the right pharyngeal mucosal
space, with notable effacement of the oropharynx  (10).
Figure 10. The MRI shows that the adjacent right mandibular body
and angle show good cortical outline. There is no definite cortical
destruction indicated  (10).
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